Abstract:Background and Objectives: An extracellular vesicle is part of a class of submicron particles derived from cells, mediating cellular crosstalk through microRNA (miRNA). MiRNA is a group of RNA molecules, each of which consists of 15-22 nucleotides and post-transcriptionally modulates gene expression. The complementary mRNAs-onto which the miRNAs hybridize-are involved in processes such as implantation, tumor suppression, proliferation, angiogenesis, and metastasis that define the entire tumor microenvironment. The endometrial biopsy is a standard technique used to recognize cellular atypia, but other non-invasive markers may reduce patient discomfort during the use of invasive methods. The present study aims to examine the distribution and the regulation of the differentially expressed miRNAs (DEMs) and EV-derived substances in women with endometrial cancer. Materials and Methods: We systematically searched the PubMed, EMBASE, Scopus, Cochrane Library, and ScienceDirect databases in April 2023, adopted the string "Endometrial Neoplasms AND Exosomes", and followed the recommendations in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. We selected all the studies that included patients with endometrial cancer and that described the regulation of miRNA molecules in that context. The differences in molecule expression between patients and controls were evaluated as significant when the proteins had a fold change of ±1.5. Results: Seventeen records fulfilled the inclusion criteria: a total of 371 patients and 273 controls were analyzed. The upregulated molecules that had the widest delta between endometrial cancer patients and controls-relative expression ≥ 1 > 3 log2(ratio)-were miR-20b-5p, miR-204-5p, miR-15a-5p, and miR-320a. In particular, miR-20b-5p and miR-204-5p were extracted from both serum and endometrial specimens, whereas miR-15a-5p was only isolated from plasma, and miR-320a was only extracted from the endometrial specimens. In parallel, the most downregulated miRNA in the endometrial cancer patients compared to the healthy subjects was miR-320a, which was found in the endometrial specimens. Conclusions: Although their epigenetic regulation remains unknown, these upregulated molecules derived from EVs are feasible markers for the early detection of endometrial cancer. The modulation of these miRNA molecules should be assessed during different treatments or if recurrence develops in response to a targeted treatment modality.

Correspondence on 'MicroRNA expression as a diagnostic parameter in early endometrial cancer by Blagojevic et al

Response to: Correspondence on 'MicroRNA expression as a diagnostic parameter in early endometrial cancer by Coada et al

MicroRNA Expression in Endometrial Cancer: Current Knowledge and Therapeutic Implications

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

MiRNAs as potential biomarkers in early breast cancer detection: a systematic review

MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer

Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma

Aberrant MicroRNA Expression in Patients With Endometrial Cancer

miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools

Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis

Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer

Absolute Quantification of Selected microRNAs Expression in Endometrial Cancer by Digital PCR

Circulating miRNAs in Breast Cancer Diagnosis and Prognosis

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients

Circulating microRNAs as Non-Invasive Biomarkers in Endometriosis Diagnosis—A Systematic Review

Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis

Identification of Four Serum Micrornas from a Genome-Wide Serum Microrna Expression Profile As Potential Non-Invasive Biomarkers for Endometrioid Endometrial Cancer

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment

MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer